Divi's Laboratories Limited NSE Symbol:DIVISLAB, BSE Security Code:532488 has declared its 1st(first) quarter un-audited Consolidated financial report from the month of April, 2020 to the month of June, 2020; for the fiscal year 2020-21.
| Revenue Reported by Divi's Laboratories Limited for First Quarter FY, 2020-21 | ||
| Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
| 17.48 | 14.66 | 11.93 |
| Calculated Revenue of Divi's Laboratories Limited for First Quarter FY, 2020-21 | |||
| Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
| Change | Change % | Change | Change % |
| 2.82 | 19.24%(Revenue Increase) | 5.55 | 46.52%(Revenue Increase) |
Revenue: Divi's Laboratories Limited's financial report shows that the company's revenue increased by 19.24% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for revenue increase of Rs.2.82 billions, as the company posted revenue of Rs.17.48 billions; in compare to previous quarter(January, 2020 - March, 2020) when the company reported revenue of Rs.14.66 billions.
The result also shows that the company's revenue increased by 46.52% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for revenue increase of Rs.5.55 billions; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted revenue of Rs.11.93 billions.
| Gross Margin(%) Reported by Divi's Laboratories Limited for First Quarter FY, 2020-21 | ||
| Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
| 82.88 | 57.13 | 50.99 |
| Calculated Gross Margin(%) of Divi's Laboratories Limited for First Quarter FY, 2020-21 | |||
| Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
| Change | Change % | Change | Change % |
| 25.75 | 45.08%(GM Increase) | 31.89 | 62.55%(GM Increase) |
Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 45.08% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for 25.75% GM increase, as the company reported 82.88% GM; in compare to previous quarter(January, 2020 - March, 2020) when the company reported 57.13% GM.
The result also indicates, the company's GM increased by 62.55% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for 31.89% GM increase; in compare to corresponding quarter(April, 2019 - June, 2019) when the company reported 50.99% GM.
| EBITDA Reported by Divi's Laboratories Limited for First Quarter FY, 2020-21 | ||
| Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
| 7.17 | 5.21 | 4.17 |
| Calculated EBITDA of Divi's Laboratories Limited for First Quarter FY, 2020-21 | |||
| Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
| Change | Change % | Change | Change % |
| 1.96 | 37.62%(EBITDA Increase) | 3.00 | 71.94%(EBITDA Increase) |
EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 37.62% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.1.96 billions, as the company posted EBITDA of Rs.7.17 billions; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EBITDA of Rs.5.21 billions.
The result also shows that the company's EBITDA increased by 71.94% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EBITDA increase of Rs.3.00 billions; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EBITDA of Rs.4.17 billions.
| Profit and Loss Reported by Divi's Laboratories Limited for First Quarter FY, 2020-21 | ||
| Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
| 4.92(Profit ) | 3.88(Profit ) | 2.72(Profit ) |
| Calculated Profit and Loss of Divi's Laboratories Limited for First Quarter FY, 2020-21 | |||
| Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
| Change | Change % | Change | Change % |
| 1.04 | 26.80%(Profit Increase) | 2.20 | 80.88%(Profit Increase) |
Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 26.80% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for profit increase of Rs.1.04 billions, as the company posted profit of Rs.4.92 billions; in compare to previous quarter(January, 2020 - March, 2020) when the company reported profit of Rs.3.88 billions.
The result also shows that the company's profit increased by 80.88% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for profit increase of Rs.2.20 billions; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted profit of Rs.2.72 billions.
| EPS Reported by Divi's Laboratories Limited for First Quarter FY, 2020-21 | ||
| Current Quarter (April, 2020 - June, 2020) | Previous Quarter (January, 2020 - March, 2020) | Corresponding Quarter (April, 2019 - June, 2019) |
| 18.54 | 14.62 | 10.26 |
| Calculated EPS of Divi's Laboratories Limited for First Quarter FY, 2020-21 | |||
| Current(June, 2020) VS Previous(March, 2020) | Current(June, 2020) VS Corresponding(June, 2019) | ||
| Change | Change % | Change | Change % |
| 3.92 | 26.81%(EPS Increase) | 8.28 | 80.70%(EPS Increase) |
EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 26.81% in QoQ(Quarter on Quarter) / current quarter(April, 2020 - June, 2020) for EPS increase of Rs.3.92, as the company posted EPS of Rs.18.54; in compare to previous quarter(January, 2020 - March, 2020) when the company reported EPS of Rs.14.62.
The result also shows that the company's EPS increased by 80.70% in YoY(Year over Year) / in current quarter(April, 2020 - June, 2020) for EPS increase of Rs.8.28; in compare to corresponding quarter(April, 2019 - June, 2019) when the company posted EPS of Rs.10.26.
***All amounts are given in Billion Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.
Comments